Dr. Megan Clowse gives 2 major tips on how rheumatologists can help avoid catastrophic pregnancies: ✳️Routinely ask open-ended Qs to promote HONEST dialogue about repro health ✳️Provide ACCURATE info & guidance using discussion guides and handouts #ACR22 @RheumNow @rheumarhyme https://t.co/qXwKMdJmR8

Infections in pre-RA: a cause or a consequence? Rheumatoid arthritis is known to be associated with a higher risk of infections, and this occurs for multiple reasons: immune dysfunction, systemic inflammation, comorbidities, and treatments. https://t.co/N91Goop92l https://t.co/yvnRrsHSCB

Emphasis that drug holiday is NOT drug retirement in osteoporosis. Ideal time to re-initiate is quite uncertain however. Continue to monitor DEXA and fracture risk factors. @RheumNow #ACR22 #osteoporosis https://t.co/iLKrxdzpAR

Valero et al. Combined biologics in PsA. @RheumNow #ACR22 Abstr1044 https://t.co/7nNf0Ktf0M https://t.co/CIE9BnBFvx

The Great Debate! Should you treat pre-clinical RA? First - likelihood of RA? If you have +ACPA or RF in sputum, there is 67% chance of developing clinical RA! @RheumNow #ACR22 https://t.co/K7pUhvbEDR

💠CYC confers a 27% risk of congenital malformations and ⬆️miscarriage rate 💠Contraception is recommended during use and 3 mos after tx #ACR22 @Rheumnow https://t.co/A73vCMZdxd

Can we predict PsA incidence and prevalence trends? Germany long-term projection 2040 3 scenarios: 1. increase 5%/yr 2. stable 3. decrease 5%/yr. Best scenario (3) = peak diagnoses in 2028. Are medical resources ready for it? https://t.co/ws87zDukuM Abs#1019 #ACR22 @Rheumnow https://t.co/dqkfrag0w2

Atypical femoral fracture risk increases over time. Risk decreases slowly as well with time off treatment. Absolute risk remains relatively low however. @RheumNow #ACR22 #osteoporosis https://t.co/pcIfhRW4WJ

💉COVID-19 vaccination in pregnant pts with rheumatic disease💉 🤰⬇️pre term births in vaccinated 🤰PPROM ⬆️ unvaccinated ✅More support 4 importance of covid vacc in our 🤰 Stellar work from covid GRA- Fantastic presentation by @Sineadm15 #ACR22 @RheumNow @RichardPAConway https://t.co/LLaLJSqS6W

Good BMD gains in switching BP->denosumab, especially in first few years. #sequentialtherapy @RheumNow #ACR22 #osteoporosis https://t.co/t1hItKn8sB